![](/img/cover-not-exists.png)
Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group
Schmiegel, W., Reinacher-Schick, A., Arnold, D., Kubicka, S., Freier, W., Dietrich, G., Geissler, M., Hegewisch-Becker, S., Tannapfel, A., Pohl, M., Hinke, A., Schmoll, H. J., Graeven, U.Volume:
24
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdt028
Date:
June, 2013
File:
PDF, 188 KB
english, 2013